Vital Therapies' Series C Round

Vital Therapies raised a round of funding on September 17, 2007.

Vital Therapies is a development-stage biotechnology company developing ELAD, an extracorporeal liver support system which functions by processing toxins and synthesizing proteins and metabolites that…

Articles about Vital Therapies' Series C Round: